title: Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus.
authors.forename: H M
authors.initials: HM
authors.lastname: Aucken
authors.forename: M
authors.initials: M
authors.lastname: Warner
authors.forename: M
authors.initials: M
authors.lastname: Ganner
authors.forename: A P
authors.initials: AP
authors.lastname: Johnson
authors.forename: J F
authors.initials: JF
authors.lastname: Richardson
authors.forename: B D
authors.initials: BD
authors.lastname: Cookson
authors.forename: D M
authors.initials: DM
authors.lastname: Livermore
mesh_terms: D000362:Agar; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D014640:Vancomycin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000362:Agar